The effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study

dc.authorid0000-0002-5941-1715
dc.authorid0000-0002-8356-3137
dc.authorid0000-0001-5976-4011
dc.authorid0000-0002-4006-1049
dc.authorid0000-0002-7555-6201
dc.authorid0000-0002-9122-8742
dc.authorid0000-0003-4776-5601
dc.contributor.authorLear, Scott A.
dc.contributor.authorHu, Weihong
dc.contributor.authorRangarajan, Sumathy
dc.contributor.authorGasevic, Danijela
dc.contributor.authorLeong, Darryl
dc.contributor.authorIqbal, Romaina
dc.contributor.authorCasanova, Amparo
dc.date.accessioned2025-05-10T19:44:02Z
dc.date.issued2017
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground Physical activity has a protective effect against cardiovascular disease (CVD) in high-income countries, where physical activity is mainly recreational, but it is not known if this is also observed in lower-income countries, where physical activity is mainly non-recreational. We examined whether different amounts and types of physical activity are associated with lower mortality and CVD in countries at different economic levels. Methods In this prospective cohort study, we recruited participants from 17 countries (Canada, Sweden, United Arab Emirates, Argentina, Brazil, Chile, Poland, Turkey, Malaysia, South Africa, China, Colombia, Iran, Bangladesh, India, Pakistan, and Zimbabwe). Within each country, urban and rural areas in and around selected cities and towns were identified to reflect the geographical diversity. Within these communities, we invited individuals aged between 35 and 70 years who intended to live at their current address for at least another 4 years. Total physical activity was assessed using the International Physical Activity Questionnaire (IPQA). Participants with pre-existing CVD were excluded from the analyses. Mortality and CVD were recorded during a mean of 6.9 years of follow-up. Primary clinical outcomes during follow-up were mortality plus major CVD (CVD mortality, incident myocardial infarction, stroke, or heart failure), either as a composite or separately. The effects of physical activity on mortality and CVD were adjusted for sociodemographic factors and other risk factors taking into account household, community, and country clustering. Findings Between Jan 1, 2003, and Dec 31, 2010, 168 916 participants were enrolled, of whom 141 945 completed the IPAQ. Analyses were limited to the 130 843 participants without pre-existing CVD. Compared with low physical activity (<600 metabolic equivalents [MET] x minutes per week or < 150 minutes per week of moderate intensity physical activity), moderate (600-3000 MET x minutes or 150-750 minutes per week) and high physical activity (> 3000 MET x minutes or > 750 minutes per week) were associated with graded reduction in mortality (hazard ratio 0.80, 95% CI 0.74-0.87 and 0.65, 0.60-0.71; p< 0.0001 for trend), and major CVD (0.86, 0.78-0.93; p< 0.001 for trend). Higher physical activity was associated with lower risk of CVD and mortality in high-income, middle-income, and low-income countries. The adjusted population attributable fraction for not meeting the physical activity guidelines was 8.0% for mortality and 4.6% for major CVD, and for not meeting high physical activity was 13.0% for mortality and 9.5% for major CVD. Both recreational and non-recreational physical activity were associated with benefits. Interpretation Higher recreational and non-recreational physical activity was associated with a lower risk of mortality and CVD events in individuals from low-income, middle-income, and high-income countries. Increasing physical activity is a simple, widely applicable, low cost global strategy that could reduce deaths and CVD in middle age.
dc.description.sponsorshipPopulation Health Research Institute; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Ontario SPOR Support Unit; Ontario Ministry of Health and Long-Term Care; AstraZeneca; Sanofi-Aventis; Boehringer Ingelheim; Servier; GSK; Novartis; King Pharma
dc.description.sponsorshipPopulation Health Research Institute, the Canadian Institutes of Health Research, Heart and Stroke Foundation of Ontario, Ontario SPOR Support Unit, Ontario Ministry of Health and Long-Term Care, AstraZeneca, Sanofi-Aventis, Boehringer Ingelheim, Servier, GSK, Novartis, King Pharma, and national and local organisations in participating countries that are listed at the end of the Article.
dc.identifier.doi10.1016/S0140-6736(17)31634-3
dc.identifier.endpage2654
dc.identifier.issn0140-6736
dc.identifier.issn1474-547X
dc.identifier.issue10113
dc.identifier.pmid28943267
dc.identifier.scopus2-s2.0-85029713110
dc.identifier.scopusqualityQ1
dc.identifier.startpage2643
dc.identifier.urihttps://doi.org/10.1016/S0140-6736(17)31634-3
dc.identifier.urihttps://hdl.handle.net/20.500.14730/10788
dc.identifier.volume390
dc.identifier.wosWOS:000418101000025
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofLancet
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectAll-Cause Mortality
dc.subjectNoncommunicable Diseases
dc.subjectHealth
dc.subjectLife
dc.subjectAffordability
dc.subjectAvailability
dc.subjectAssociation
dc.subjectWorldwide
dc.subjectWalking
dc.subjectBurden
dc.titleThe effect of physical activity on mortality and cardiovascular disease in 130 000 people from 17 high-income, middle-income, and low-income countries: the PURE study
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
10788.pdf
Boyut:
1.34 MB
Biçim:
Adobe Portable Document Format